the Safety, Tolerability and Pharmacokinetics of Mulberry Twig Alkaloids in Human
Clinical trial NCT06490263 · COMPLETED
Trial details
- NCT number
- NCT06490263
- Sponsor
- Beijing Wehand-Bio Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-13
- Primary completion
- 2024-10-19
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.